Evelo Biosciences Inc (EVLO)
OTHER OTC:EVLO
US Market
Holding EVLO?
Track your performance easily

Evelo Biosciences (EVLO) Balance Sheet

214 Followers

Evelo Biosciences Balance Sheet

Evelo Biosciences's total assets for Q3 2023 were $20.63M, a decrease of -0.92% from the previous quarter. EVLO total liabilities were $47.33M for the fiscal quarter, a -29.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 64.44M$ 87.87M$ 90.64M$ 90.92M$ 159.87M
Total Liabilities
$ 69.43M$ 79.20M$ 60.15M$ 30.72M$ 22.92M
Total Equity Gross Minority
$ -4.97M$ 8.67M$ 30.48M$ 60.20M$ 136.95M
Total Capitalization
$ 87.50M$ 109.57M$ 100.57M$ 79.83M$ 149.25M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Evelo Biosciences Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis